Aryan Gupta’s sanitation rover replaces unsafe manual drain cleaning with a remotely operated, low-cost robot that protects ...
When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...
At least 24 termination letters have been sent out, according to one official. Several active research grants related to studies involving LGBTQ+ issues, gender identity and diversity, equity and ...
HOUSTON, Oct. 8, 2025 /PRNewswire/ -- Western Midstream Partners, LP (NYSE: WES) ("WES") and Aris Water Solutions, Inc. (NYSE: ARIS) ("Aris") jointly announced today the preliminary results of the ...
I sat terrified and alone atop a gurney, awaiting the scheduled time for my cystectomy, holding a clipboard with forms to complete as the nurse rushed off to do something else. There was a box to ...
Should we genetically modify wild lions? Of course not, might be your instant response. But what if lions were being wiped out by a devastating disease introduced by people? What if the genetic change ...
The omnipresence of Jamie Carragher means you’re never far away from being subject to his latest opinion, and the former Liverpool stalwart has been scathing of Arne Slot’s champions. The Reds ...
Brad LaCour is a Senior List Writer for Collider. Based out of Los Angeles, California, Brad lives close enough to the stars but is too busy to find out where exactly they live. Brad is fairly certain ...
Tropical Storm Imelda became the fourth hurricane of the 2025 season off Florida's coast Tuesday morning, Sept. 30, according to the National Hurricane Center. Hurricane Imelda is a Category 1 storm, ...
Hurricane Imelda formed as a Category 1 storm and is forecast to move away from Florida. The storm is expected to strengthen as it moves northeast toward Bermuda. Florida's east coast can expect ...
Drinking any amount of alcohol likely increases the risk of dementia, suggests the largest combined observational and genetic study to date, published in BMJ Evidence-Based Medicine. Even light ...
A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 weeks in adults with overweight or obesity. Rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results